Alex is the Chief Operating Officer of Precision BioSciences with broad industry experience built over his 30+ year career, and deep institutional knowledge. Alex joined Precision BioSciences in October 2020 and prior to his current role he served as the company’s Chief Financial Officer where he guided Precision through multiple equity offerings and divestitures to extend the company’s operational runway.

He joined Precision from Allergan, where he served as Executive Vice President, Corporate Affairs and Chief Communications Officer and President of The Allergan Foundation. In these roles, Alex developed internal and external messaging that shaped the company culture and supported several successful company transformations including the 2020 acquisition by AbbVie. Previously, Alex served as Senior Vice President, Chief Integration Officer for Actavis where he led back-to-back integration efforts for both the acquisition of Forest Labs and Allergan. Prior to this role, he was Senior Vice President, Chief Communications Officer, Public Affairs and Investor Relations and led integration efforts at Forest Labs. In addition, Alex has held senior roles at Bausch + Lomb, Merck, Schering-Plough and Novartis. He began his career in pharmaceutical sales at Pharmacia and Pharmacia & Upjohn.

He earned his Bachelor of Science in Pharmacy from Purdue University.